1. Academic Validation
  2. Identification of alpha-substituted acylamines as novel, potent, and orally active mGluR5 negative allosteric modulators

Identification of alpha-substituted acylamines as novel, potent, and orally active mGluR5 negative allosteric modulators

  • Bioorg Med Chem Lett. 2015 Aug 15;25(16):3135-41. doi: 10.1016/j.bmcl.2015.06.008.
Keita Yoshikawa 1 Tomofumi Ohyama 2 Eiki Takahashi 2 Yoshitaka Numajiri 2 Mitsuhiro Konno 2 Masaki Moriyama 2 Natsumi Takemi 2 Kana Kunita 2 Kazumi Nishimura 2 Ryoji Hayashi 2
Affiliations

Affiliations

  • 1 Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan. Electronic address: Keita_Yoshikawa@nts.toray.co.jp.
  • 2 Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
Abstract

This Letter describes the identification of a series of novel non-acetylenic mGluR5 negative allosteric modulators based on the alpha-substituted acylamine structure. An initial structure-activity relationship study suggested that (R)-19b and (R)-19j might have good in vitro activity. When administered orally, these compounds were found to have an anxiolytic-like effect in a mouse model of stress-induced hyperthermia.

Keywords

Acylamines; Metabotropic glutamate receptor; mGluR5 negative allosteric modulators.

Figures